首页> 外文期刊>Cases Journal >A case of aspergillus endophthalmitis in an immuncompetent woman: intra-ocular penetration of oral voriconazole: a case report
【24h】

A case of aspergillus endophthalmitis in an immuncompetent woman: intra-ocular penetration of oral voriconazole: a case report

机译:一名有免疫能力的妇女的曲霉性眼内炎病例:口服伏立康唑眼内渗透:一例报告

获取原文
           

摘要

Background There are very few reports of Aspergillus fumigatus causing endogenous endophthalmitis (EAE) in immunocompetent individuals although it is well recognised in the immunocompromised. Treatment can be with intravitreal, intravenous and oral antifungal agents. The benefit of an oral agent is clear however the concentration of voriconazole in the inflamed eye after oral administration has not previously been documented. Case presentation We present a case of EAE in an immunocompetent 78-year-old Caucasian female who was subsequently managed with oral voriconazole. Using a bioassay, we show an appropriate voriconazole concentration in serum and vitreous samples. Conclusion This case adds to the limited literature on the prevalence of endogenous endophthalmitis in immunocompetent patients and supports the use of voriconazole in such cases.
机译:背景技术很少有关于烟曲霉在免疫能力强的个体中引起内源性眼内炎(EAE)的报道,尽管在免疫功能低下已广为人知。可以使用玻璃体内,静脉内和口服抗真菌药进行治疗。口服剂的好处是显而易见的,但是口服给药后伏立康唑在发炎眼中的浓度尚未见文献记载。病例介绍我们介绍了一名具有免疫能力的78岁白人女性的EAE病例,随后接受口服伏立康唑治疗。使用生物测定,我们显示了血清和玻璃体样品中伏立康唑的适当浓度。结论该病例增加了有关免疫功能正常患者内源性眼内炎患病率的文献报道,并支持在这种情况下使用伏立康唑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号